IN2014DE00193A - - Google Patents

Info

Publication number
IN2014DE00193A
IN2014DE00193A IN193DE2014A IN2014DE00193A IN 2014DE00193 A IN2014DE00193 A IN 2014DE00193A IN 193DE2014 A IN193DE2014 A IN 193DE2014A IN 2014DE00193 A IN2014DE00193 A IN 2014DE00193A
Authority
IN
India
Prior art keywords
arthritis
collagen
administration
relates
present
Prior art date
Application number
Inventor
Paul Dijkstra
Francis Chun LAU
James Lugo
Original Assignee
Interhealth Nutraceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Interhealth Nutraceuticals Inc filed Critical Interhealth Nutraceuticals Inc
Publication of IN2014DE00193A publication Critical patent/IN2014DE00193A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/34—Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The present invention relates to a method of treating exercise-induced joint pain in arthritis-free mammals by the administration of undenatured Type II collagen.
IN193DE2014 2013-10-24 2014-01-21 IN2014DE00193A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201361895332P 2013-10-24 2013-10-24

Publications (1)

Publication Number Publication Date
IN2014DE00193A true IN2014DE00193A (en) 2015-05-01

Family

ID=51610711

Family Applications (1)

Application Number Title Priority Date Filing Date
IN193DE2014 IN2014DE00193A (en) 2013-10-24 2014-01-21

Country Status (14)

Country Link
US (1) US9066926B2 (en)
KR (1) KR101664290B1 (en)
AR (1) AR095104A1 (en)
AU (1) AU2014202041B8 (en)
BR (1) BR112014011741A2 (en)
CA (1) CA2846644C (en)
CL (1) CL2014001281A1 (en)
CO (1) CO7020846A2 (en)
IN (1) IN2014DE00193A (en)
MX (1) MX347669B (en)
MY (1) MY180106A (en)
PH (1) PH12014501453B1 (en)
SG (1) SG11201403524RA (en)
WO (1) WO2015060888A1 (en)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10226513B2 (en) 2015-01-09 2019-03-12 Mark Terrell Smith Method and composition to prevent or improve symptoms of musculoskeletal distress degeneration
WO2018052695A1 (en) * 2016-09-16 2018-03-22 Boston Scientific Neuromodulation Corporation System for pain management using heart sounds
US10610688B2 (en) 2016-09-27 2020-04-07 Boston Scientific Neuromodulation Corporation Systems and methods for closed-loop pain management
EP3932298A1 (en) 2016-09-27 2022-01-05 Boston Scientific Neuromodulation Corporation System for pain management using objective pain measure
US11793217B1 (en) 2016-10-04 2023-10-24 Lonza Greenwood Llc Method of manufacture and pasteurization of products containing undenatured collagen
US11850324B2 (en) 2016-10-12 2023-12-26 Advanced Biomatrix, Inc. Three-dimensional (3-D) printing inks made from natural extracellular matrix molecules
EP3532155A1 (en) 2016-10-25 2019-09-04 Boston Scientific Neuromodulation Corporation System for pain management using baroreflex sensitivity
US10729905B2 (en) 2017-01-11 2020-08-04 Boston Scientific Neuromodulation Corporation Pain management based on muscle tension measurements
US11089997B2 (en) 2017-01-11 2021-08-17 Boston Scientific Neuromodulation Corporation Patient-specific calibration of pain quantification
US10675469B2 (en) 2017-01-11 2020-06-09 Boston Scientific Neuromodulation Corporation Pain management based on brain activity monitoring
US10926091B2 (en) 2017-01-11 2021-02-23 Boston Scientific Neuromodulation Corporation Pain management based on emotional expression measurements
US10631777B2 (en) 2017-01-11 2020-04-28 Boston Scientific Neuromodulation Corporation Pain management based on functional measurements
US10631776B2 (en) 2017-01-11 2020-04-28 Boston Scientific Neuromodulation Corporation Pain management based on respiration-mediated heart rates
US10960210B2 (en) 2017-02-10 2021-03-30 Boston Scientific Neuromodulation Corporation Method and apparatus for pain management with sleep detection
CN106713191B (en) * 2017-02-28 2020-09-08 西安电子科技大学 Multi-stage search SAGE method
CN107048412A (en) * 2017-04-26 2017-08-18 北京盛美诺生物技术有限公司 A kind of masticatory pattern product containing typeⅡ Collagen
EP3936185A1 (en) 2017-07-18 2022-01-12 Boston Scientific Neuromodulation Corporation Sensor-based pain management systems and methods
JP2020531587A (en) * 2017-08-21 2020-11-05 ロンザ，エルエルシー Compositions and nutritional supplements made from them
WO2019046735A1 (en) 2017-08-31 2019-03-07 Lonza Inc. Health promoting composition and methods of use supplement related applications
IT201700111939A1 (en) * 2017-10-05 2019-04-05 Jointherapeutics S R L PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF INFLAMMATORY STATES
WO2020018504A1 (en) * 2018-07-16 2020-01-23 Lonza Inc. Collagen and cell matter supplement and method for administering same
WO2021016665A1 (en) * 2019-07-30 2021-02-04 Atp Institute Pty Ltd A gummy composition
EP4037503A1 (en) 2019-09-30 2022-08-10 Lonza Consumer Health Inc. Cannabinoid product for improving musculoskeletal health
AU2021213722A1 (en) * 2020-01-29 2022-07-28 Lonza Greenwood Llc Joint health composition and use thereof in healthy mammals
WO2021178291A1 (en) 2020-03-03 2021-09-10 Lonza Consumer Health Inc. Undenatured type ii collagen in food and beverage applications and uses thereof
JP2023518688A (en) 2020-03-24 2023-05-08 ロンザ・グリーンウッド・エルエルシー Undenatured Type II Collagen in Animal Foods and Treats
EP4146251A1 (en) 2020-06-12 2023-03-15 Lonza Greenwood LLC Undenatured type ii collagen as a supplement for improved endurance, lipid metabolism, and oxidative stress
WO2022040026A1 (en) * 2020-08-19 2022-02-24 Lonza Consumer Health Inc. Method for improving inflammation, joint health, joint mobility, and joint comfort in healthy mammals
CN115120618B (en) * 2021-03-23 2024-01-26 安徽盛美诺生物技术有限公司 Cartilage extract with immune response improving effect, preparation method and application thereof

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5399347A (en) 1987-06-24 1995-03-21 Autoimmune, Inc. Method of treating rheumatoid arthritis with type II collagen
CA2100092A1 (en) 1991-11-08 1993-05-09 Gunilla Lofgren Nisser Auxiliary means provided for treatment of visual and/or brain disorder
US5645851A (en) 1994-02-28 1997-07-08 Moore; Eugene R. Product for alleviating the symptons of arthritis in mammals
US5637321A (en) 1994-02-28 1997-06-10 Moore; Eugene R. Method for preparing animal tissue for use in alleviating the symptoms of arthritis in mammals
US5529786A (en) 1994-02-28 1996-06-25 Moore; Eugene R. Process and product for treatment of rheumatoid arthritis
US6162787A (en) * 1999-04-02 2000-12-19 Immudyne, Inc. Methods for treating arthritis using collagen type II, glucosamine chondroitin sulfate, and compositions
US6372794B1 (en) * 1999-08-26 2002-04-16 Marcel E. Nimni Method for alleviating arthritis in mammals
US20020086070A1 (en) 2000-03-11 2002-07-04 Kuhrts Eric Hauser Anti-inflammatory and connective tissue repair formulations
US7083820B2 (en) 2000-09-29 2006-08-01 Schilling Marvin L Method for producing biologically active products
JP2003048850A (en) 2001-06-01 2003-02-21 Nippon Meat Packers Inc Therapeutic agent of arthropathy, and functional food
US20060062859A1 (en) * 2004-08-05 2006-03-23 Kenneth Blum Composition and method to optimize and customize nutritional supplement formulations by measuring genetic and metabolomic contributing factors to disease diagnosis, stratification, prognosis, metabolism, and therapeutic outcomes
FR2900155B1 (en) 2006-04-21 2008-06-27 Diana Naturals Sa AVIAN CARTILAGE HYDROLISATE, PROCESS FOR OBTAINING AND USES
US20100215731A1 (en) 2009-02-20 2010-08-26 Maastricht University Method for improving cartilage repair and/or preventing cartilage degeneration in a joint
US20110218151A1 (en) * 2010-03-04 2011-09-08 Joar Opheim Substances for promoting healthy joint function comprising omega-3 polyunsaturated fatty acids or drivatives thereof, undenatured type ii collagen and, optionally, glucosamine sulfate
CN101822684B (en) 2010-05-27 2012-08-15 江苏江山制药有限公司 Compound combined preparation for preventing osteoarticular pain and preparation method thereof
US20120294898A1 (en) 2011-05-19 2012-11-22 Warsaw Orthopedic, Inc. Injectable dbm for soft tissue repair
CN102423487B (en) 2011-12-23 2014-04-16 内蒙古伊利实业集团股份有限公司 Osteoarticular health-care composition and its application
CN103203012A (en) 2012-01-12 2013-07-17 深圳市麦金利实业有限公司 Joint health care product

Also Published As

Publication number Publication date
WO2015060888A1 (en) 2015-04-30
KR101664290B1 (en) 2016-10-11
CL2014001281A1 (en) 2015-10-30
PH12014501453A1 (en) 2015-01-21
US20150119335A1 (en) 2015-04-30
CO7020846A2 (en) 2014-08-11
BR112014011741A2 (en) 2017-05-30
US9066926B2 (en) 2015-06-30
MX2014002934A (en) 2015-09-21
MX347669B (en) 2017-05-08
AR095104A1 (en) 2015-09-30
CA2846644A1 (en) 2015-07-13
PH12014501453B1 (en) 2015-01-21
SG11201403524RA (en) 2015-05-28
AU2014202041A1 (en) 2015-05-14
AU2014202041B2 (en) 2019-11-28
CA2846644C (en) 2018-05-01
AU2014202041B8 (en) 2020-04-02
MY180106A (en) 2020-11-23
KR20150059132A (en) 2015-05-29

Similar Documents

Publication Publication Date Title
IN2014DE00193A (en)
CY1123065T1 (en) RECOMBINATED PROBIOTIC BACTERIA
MX2018012166A (en) Oral dosing of glp-1 compounds.
GB201711353D0 (en) Improvements relating to face recognition
UA110813C2 (en) Treatment of lipodystrophy
MX2015014500A (en) Combination therapy of antibodies against human csf-1r and tlr9 agonist.
ECSP15043422A (en) A PROCEDURE TO INCREASE THE FORMATION OF PYROGLUTAMIC ACID FROM A PROTEIN
MX2018004831A (en) Methods of making fucosylated and afucosylated forms of a protein.
EA201791110A1 (en) SUBLINGUAL INTRODUCTION OF RHYNESOL
EA201600026A1 (en) BACTERIAL HYALURONIDASE AND METHOD FOR ITS PRODUCTION
PH12016500598A1 (en) Protoxin-ii variants and methods of use
MY190747A (en) Method for producing silazane-siloxane copolymers and the use of such copolymers
EA201692534A1 (en) METHODS OF TREATMENT OF HYPOTHONY
EA201690855A1 (en) ENDOGLIN PEPTIDES FOR THE TREATMENT OF FIBROZAL DISEASES
MX2015013066A (en) Therapeutic uses for vegfr1 antibodies.
MX359181B (en) Collagen hydrolysate and use thereof.
EA201690075A1 (en) METHOD OF TREATMENT OF INTRACELLULAR INFECTION
EA201690446A1 (en) TREATMENT OF MULTIPLE MYELOMA
MX2016005645A (en) Topical pharmaceutical composition of acitretin.
EA201691036A1 (en) NEW CONNECTION FOR THE TREATMENT OF HEAVY HYPOGLYCEMIA
EA201690914A1 (en) NEW CONNECTION FOR THE TREATMENT OF HEAVY HYPOGLYCEMIA
EA201690445A1 (en) CANCER TREATMENT
MX370176B (en) Method for preventing and/or treating chronic traumatic encephalopathy-i.
MX2015011881A (en) Process for the preparation of 3,7-dimethylnonan-1-ol.
CY1119212T1 (en) USE OF ODIPARCIL IN THE TREATMENT OF A MYCOPOLYSAKHARIDOSIS